Vixcef comprimidos

Array
(
    [ID] => 1556
    [post_author] => 16
    [post_date] => 2012-07-06 19:37:56
    [post_date_gmt] => 2012-07-06 19:37:56
    [post_content] => 
Forma farmacéutica:
Comprimidos Recubiertos
Composición:
Cada comprimido recubierto contiene:

Cefixima (como Cefixima Trihidrato) 400 mg
Acción Terapéutica:
Antibiótico cefalosporínico de tercera generación para administración oral, con acción bactericida frente a un amplio espectro de gérmenes gram-positivos y gram-negativos, incluyendo cepas productoras de betalactamasas.
Indicaciones:
Vixcef está indicado para el tratamiento de las siguientes infecciones causadas por microorganismos sensibles:
-Infecciones respiratorias (bronquitis aguda, exacerbación aguda de la bronquitis crónica).
-Infecciones otorrinolaringológicas (amigdalitis, otitis media aguda, sinusitis).
-Infecciones urinarias agudas o crónicas no complicadas (cistitis, pielonefritis).
-Gonorrea aguda no complicada (cervicitis, uretritis).
Presentaciones:
Envases conteniendo 6 y 12 comprimidos
    [post_title] => Vixcef comprimidos
    [post_excerpt] => Antibiótico cefalosporínico semisintético para administración oral con acción bactericida frente a un amplio espectro de gérmenes grampositivos
y gramnegativos, incluidos los productores de betalactamasas.
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => vixcef
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2024-11-28 10:56:59
    [post_modified_gmt] => 2024-11-28 13:56:59
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://www.bago.com.ar/vademecum//?post_type=productos&p=1556
    [menu_order] => 0
    [post_type] => productos
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
    [prospecto_para_pacientes] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19757
                    [post_author] => 16
                    [post_date] => 2024-11-28 10:50:35
                    [post_date_gmt] => 2024-11-28 13:50:35
                    [post_content] => 
                    [post_title] => VIXCEF CoR Información paciente Disp. 12816-17
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => vixcef-cor-informacion-paciente-disp-12816-17
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-11-28 10:50:35
                    [post_modified_gmt] => 2024-11-28 13:50:35
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => http://www.bago.com.ar/vademecum/wp-content/uploads/2024/11/VIXCEF-CoR-Informacion-paciente-Disp.-12816-17.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [url_para_mayor_informacion_video] => 
    [url_para_mayor_informacion] => 
    [url_productos_consumo_masivo] => 
    [prospecto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19756
                    [post_author] => 16
                    [post_date] => 2024-11-28 10:50:34
                    [post_date_gmt] => 2024-11-28 13:50:34
                    [post_content] => 
                    [post_title] => VIXCEF CoR Prospecto Disp. 12816-17
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => vixcef-cor-prospecto-disp-12816-17
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-11-28 10:50:34
                    [post_modified_gmt] => 2024-11-28 13:50:34
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => http://www.bago.com.ar/vademecum/wp-content/uploads/2024/11/VIXCEF-CoR-Prospecto-Disp.-12816-17.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [presentacion_img] => Array
        (
        )

    [logo_img] => Array
        (
        )

    [foto_producto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19758
                    [post_author] => 16
                    [post_date] => 2024-11-28 10:55:35
                    [post_date_gmt] => 2024-11-28 13:55:35
                    [post_content] => 
                    [post_title] => img_prod_vixcef400
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => img_prod_vixcef400
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-11-28 10:55:35
                    [post_modified_gmt] => 2024-11-28 13:55:35
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => http://www.bago.com.ar/vademecum/wp-content/uploads/2024/11/img_prod_vixcef400.png
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => image/png
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [fotos_lanzamiento] => Array
        (
        )

    [especialidad] => Array
        (
        )

    [marca] => Array
        (
            [0] => Vixcef
        )

    [principio_activo] => Array
        (
            [0] => Cefixima
        )

    [post_content_formatted] => 
Forma farmacéutica:
Comprimidos Recubiertos
Composición:
Cada comprimido recubierto contiene:
Cefixima (como Cefixima Trihidrato) 400 mg
Acción Terapéutica:
Antibiótico cefalosporínico de tercera generación para administración oral, con acción bactericida frente a un amplio espectro de gérmenes gram-positivos y gram-negativos, incluyendo cepas productoras de betalactamasas.
Indicaciones:
Vixcef está indicado para el tratamiento de las siguientes infecciones causadas por microorganismos sensibles:

-Infecciones respiratorias (bronquitis aguda, exacerbación aguda de la bronquitis crónica).

-Infecciones otorrinolaringológicas (amigdalitis, otitis media aguda, sinusitis).

-Infecciones urinarias agudas o crónicas no complicadas (cistitis, pielonefritis).

-Gonorrea aguda no complicada (cervicitis, uretritis).
Presentaciones:
Envases conteniendo 6 y 12 comprimidos

)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => prospectos/VIXCEF-CoR-Prospecto-Disp.-12816-17.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:8:"filesize";i:504994;}
        )

)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => 2024/11/VIXCEF-CoR-Informacion-paciente-Disp.-12816-17.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:8:"filesize";i:3374279;}
        )

)

anexo_congre_single